Adage Capital Partners’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-994,738
| Closed | -$14M | – | 875 |
|
|
2024
Q2 | $14M | Sell |
994,738
-916,245
| -48% | -$12.9M | 0.03% | 527 |
|
|
2024
Q1 | $32.3M | Buy |
1,910,983
+1,685,983
| +749% | +$28.5M | 0.06% | 333 |
|
|
2023
Q4 | $3.18M | Sell |
225,000
-1,500,000
| -87% | -$21.2M | 0.01% | 723 |
|
|
2023
Q3 | $17.8M | Sell |
1,725,000
-955,000
| -36% | -$9.84M | 0.04% | 424 |
|
|
2023
Q2 | $44.2M | Buy |
+2,680,000
| New | +$44.2M | 0.1% | 212 |
|